Amneal Pharmaceuticals, Inc. AMRX Restructuring Charges
Discontinued — last reported Q1 '26
Restructuring Charges at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s restructuring charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s restructuring charges?
- Amneal Pharmaceuticals, Inc. (AMRX) reported restructuring charges of $650K in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s restructuring charges changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s restructuring charges increased by 13.8% year-over-year, from $571K to $650K.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s restructuring charges?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s restructuring charges has grown at a 22.7% compound annual growth rate (CAGR), from $1.86M to $4.21M.
- What does restructuring charges mean?
- One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.